USD 4.5B of VC / PE investment seen in Lifesciences spaces in December 2020

We recorded 78 VC/PE transactions pertaining to the global life sciences sector for Dec 2020, aggregating to a sum of USD 4.5B. USA recorded 46 transactions for with total investment of USD 2.1B. China reported investment of USD 1.9B over 14 VC/PE transactions. China also reported 3 IPOs  aggregating a…

Read More

USD 4.7B of VC/PE investment seen in Lifesciences spaces in November 2020

We recorded 81 VC/PE transactions pertaining to the global life sciences sector for Nov 2020, aggregating to a sum of USD 4.7B. USA recorded 46 transactions for with total investment of USD 2.5B. Around 67% of investment, spread over 40 transactions, went into supporting R&D stage companies. Vaccine companies continued…

Read More

Burger King has outperformed McDonald’s partner WestLife

An IPO of a company in the food business always arouses market interest. The IPO of Burger King India Limited opens next week. While going through the RHP, one data point struck us as interesting: since Burger King entered the market in India, it has matched WestLife Development for incremental…

Read More

Chemcrux delivers steady performance in FY21 first half despite Covid

Chemcrux Enterprise is a Specialty Chemical company listed on the BSE SME platform. Chemcrux manufactures import-substitute chemicals that go into manufacture of pharma APIs and pigments. Some of its key products are variants of Chloro Benzoic Acids and Nitro Benzoic Acid. The company’s results for first half of FY20-21 show…

Read More

Growth returned to the cement industry in Jul-Sep’20 quarter

Growth in the cement industry came back in Jul-Sep’20 quarter, as can be seen from the results of India’s top 2 cement companies. From the investor deck of India’s largest cement company Ultratech Cements: Cement demand rebound in Q2 FY21, with most regions reporting YoY growth. Volume growth was 8%…

Read More

USD 5.6B of investments into Lifesciences startups in September’20

We recorded 96 VC/PE transactions pertaining to the global life sciences sector for Sep 2020, aggregating to a sum of USD 5.6B. USA recorded 52 transactions for with total investment of USD 2.6B. China reported investment of USD 1.5B over 16 VC/PE transactions. China also reported 2 IPOs aggregating to…

Read More

CL Educate recovers from Covid Blues

Shares of CL Educate have done well since August 20. CL’s share price was Rs 38 at the end of July. The price rose to Rs 46.5, and is now around Rs 70. This is a smart recovery after the fall CL’s shares had suffered in March due to Covid…

Read More

China’s lifescience sector receives more VC/PE investment in Aug’20 compared to the USA

Aug’20 saw China’s lifescience sector receive more VC/PE investment than the USA for the second time ever in terms of monthly recorded amounts, with the first instance being in Apr’20. For Aug’20, China reported USD 2024m of venture capital investments, as compared to USD 1531m recorded by the USA. China…

Read More

July was a landmark month for Chinese Biotech

China’s biotech sector continues to blossom as far as fund raising goes. For 4 months in a row, the sector is witnessing increasing amounts of fund raise. While private deals (VC/PE) led the increase in April and May, in June and July, it is public market fund raising that drove…

Read More

SEBI, when can Indian markets see SPACs?

After almost 30 years of moving towards a capitalistic market model, India still has a long way to go. Efficient allocation of capital, risk taking, animal spirits: we don’t truly get this. Banking system is stuck in NPA mess, which the bankruptcy law IBC has not been able to make…

Read More